Mydecine Innovations Group Inc. (MYCOF)
OTCMKTS · Delayed Price · Currency is USD
0.0065
+0.0010 (18.25%)
At close: Aug 1, 2025
MYCOF Market Cap
MYCOF has a market cap or net worth of $400.18 thousand as of August 1, 2025. Its market cap has decreased by -45.15% in one year.
Market Cap
400.18K
Enterprise Value
5.55M
Revenue
n/a
Ranking
n/a
PE Ratio
2.47
Stock Price
$0.01
Market Cap Chart
Since May 8, 2015, MYCOF's market cap has decreased from 8.91M to 400.18K, a decrease of -95.51%. That is a compound annual growth rate of -26.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 400.18K | 131.43% |
| Dec 31, 2024 | 172.92K | -77.92% |
| Dec 29, 2023 | 783.26K | -85.99% |
| Dec 30, 2022 | 5.59M | -80.55% |
| Dec 31, 2021 | 28.75M | -53.51% |
| Dec 31, 2020 | 61.86M | 1,508.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 563.22M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |